<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Doudesis D</submitter><funding>British Heart Foundation</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><pagination>e300-e308</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9052331</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Diagnostic pathways for myocardial infarction rely on fixed troponin thresholds, which do not recognise that troponin varies by age, sex, and time within individuals. To overcome this limitation, we recently introduced a machine learning algorithm that predicts the likelihood of myocardial infarction. Our aim was to evaluate whether this algorithm performs well in routine clinical practice and predicts subsequent events.&lt;h4>Methods&lt;/h4>The myocardial-ischaemic-injury-index (MI&lt;sup>3&lt;/sup>) algorithm was validated in a prespecified exploratory analysis using data from a multi-centre randomised trial done in Scotland, UK that included consecutive patients with suspected acute coronary syndrome undergoing serial high-sensitivity cardiac troponin I measurement. Patients with</pubmed_abstract><journal>The Lancet. Digital health</journal><pubmed_title>Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis.</pubmed_title><pmcid>PMC9052331</pmcid><funding_grant_id>FS/CRTF/21/24273</funding_grant_id><funding_grant_id>RG/20/10/34966</funding_grant_id><funding_grant_id>BCDSA/100003</funding_grant_id><funding_grant_id>SP/12/10/29922</funding_grant_id><funding_grant_id>CH/09/002/26360</funding_grant_id><funding_grant_id>CH/F/21/90010</funding_grant_id><funding_grant_id>MR/N013166/1</funding_grant_id><funding_grant_id>AI_AWARD02322</funding_grant_id><funding_grant_id>RE/18/5/34216</funding_grant_id><funding_grant_id>FS/18/25/33454</funding_grant_id><funding_grant_id>MR/V007017/1</funding_grant_id><pubmed_authors>Ford I</pubmed_authors><pubmed_authors>Weir CJ</pubmed_authors><pubmed_authors>Andrews JP</pubmed_authors><pubmed_authors>Sadat I</pubmed_authors><pubmed_authors>Taggart C</pubmed_authors><pubmed_authors>Doudesis D</pubmed_authors><pubmed_authors>McAllister DA</pubmed_authors><pubmed_authors>MacDonald C</pubmed_authors><pubmed_authors>Strachan FE</pubmed_authors><pubmed_authors>McKinlay L</pubmed_authors><pubmed_authors>Fischbacher C</pubmed_authors><pubmed_authors>Linksted P</pubmed_authors><pubmed_authors>Fox KA</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Vallejos CA</pubmed_authors><pubmed_authors>Sandeman D</pubmed_authors><pubmed_authors>Walker S</pubmed_authors><pubmed_authors>Berry C</pubmed_authors><pubmed_authors>Parker RA</pubmed_authors><pubmed_authors>Chapman AR</pubmed_authors><pubmed_authors>Maguire D</pubmed_authors><pubmed_authors>Young S</pubmed_authors><pubmed_authors>Amoils S</pubmed_authors><pubmed_authors>Mendusic F</pubmed_authors><pubmed_authors>Leslie SJ</pubmed_authors><pubmed_authors>Anand A</pubmed_authors><pubmed_authors>Charles H</pubmed_authors><pubmed_authors>Stables CL</pubmed_authors><pubmed_authors>Norrie J</pubmed_authors><pubmed_authors>Hautvast M</pubmed_authors><pubmed_authors>Tsanas A</pubmed_authors><pubmed_authors>Stevens J</pubmed_authors><pubmed_authors>Malo J</pubmed_authors><pubmed_authors>Stewart SD</pubmed_authors><pubmed_authors>Hung J</pubmed_authors><pubmed_authors>McPherson J</pubmed_authors><pubmed_authors>Alexander B</pubmed_authors><pubmed_authors>Shah AS</pubmed_authors><pubmed_authors>Apple FS</pubmed_authors><pubmed_authors>Walker A</pubmed_authors><pubmed_authors>Harkess R</pubmed_authors><pubmed_authors>Lowry MT</pubmed_authors><pubmed_authors>Findlay I</pubmed_authors><pubmed_authors>Tuck C</pubmed_authors><pubmed_authors>Mills NL</pubmed_authors><pubmed_authors>Anwar MS</pubmed_authors><pubmed_authors>High-STEACS Investigators</pubmed_authors><pubmed_authors>Pickering JW</pubmed_authors><pubmed_authors>Reid A</pubmed_authors><pubmed_authors>Marshall L</pubmed_authors><pubmed_authors>Cruikshank A</pubmed_authors><pubmed_authors>Fujisawa T</pubmed_authors><pubmed_authors>Duncan C</pubmed_authors><pubmed_authors>Collinson PO</pubmed_authors><pubmed_authors>Finlay F</pubmed_authors><pubmed_authors>Than MP</pubmed_authors><pubmed_authors>Bularga A</pubmed_authors><pubmed_authors>Kimenai DM</pubmed_authors><pubmed_authors>Newby DE</pubmed_authors><pubmed_authors>Moss A</pubmed_authors><pubmed_authors>Ferry AV</pubmed_authors><pubmed_authors>Stirling L</pubmed_authors><pubmed_authors>Adamson PD</pubmed_authors><pubmed_authors>Shah ASV</pubmed_authors><pubmed_authors>Gray A</pubmed_authors><pubmed_authors>Croal BL</pubmed_authors><pubmed_authors>Keerie C</pubmed_authors><pubmed_authors>Lee KK</pubmed_authors><pubmed_authors>Wereski R</pubmed_authors><pubmed_authors>Armstrong R</pubmed_authors><pubmed_authors>Wackett T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis.</name><description>&lt;h4>Background&lt;/h4>Diagnostic pathways for myocardial infarction rely on fixed troponin thresholds, which do not recognise that troponin varies by age, sex, and time within individuals. To overcome this limitation, we recently introduced a machine learning algorithm that predicts the likelihood of myocardial infarction. Our aim was to evaluate whether this algorithm performs well in routine clinical practice and predicts subsequent events.&lt;h4>Methods&lt;/h4>The myocardial-ischaemic-injury-index (MI&lt;sup>3&lt;/sup>) algorithm was validated in a prespecified exploratory analysis using data from a multi-centre randomised trial done in Scotland, UK that included consecutive patients with suspected acute coronary syndrome undergoing serial high-sensitivity cardiac troponin I measurement. Patients with</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2026-05-10T00:50:53.944Z</modification><creation>2024-11-15T17:59:07.623Z</creation></dates><accession>S-EPMC9052331</accession><cross_references><pubmed>35461689</pubmed><doi>10.1016/S2589-7500(22)00025-5</doi></cross_references></HashMap>